Radiopharm Theranostics Ltd (RADX) Form 6-K — Aug 3, 2026
Radiopharm Theranostics Ltd has applied for the quotation of 408,839,531 ordinary fully paid shares on the Australian Securities Exchange. These shares were issued as part of Tranche 1 of the Australian Placement at a price of AUD 0.015 per share. Following this quotation, the company's total issued ordinary share capital will increase to approximately 4.34 billion shares. The company also disclosed that further issuances are pending to complete the transaction, including an additional 40 million ordinary shares and over 448 million options expiring in 2029.
Key figures
- Offering Price
- AUD 0.01500000
- Shares Offered
- 408839531
- Shares Outstanding
- 4,337,549,491
- Future options
- 448,839,531
- Future ordinary shares
- 40,000,000
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.